Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-04-28

Clinical Trial Update: Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients? [NA]

View source ↗

Summary

This clinical trial update examines whether 3 months of vitamin D plus pegylated interferon and ribavirin improves sustained virologic response in genotype 2 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegylated interferon alfa-2a (Peginterferon alfa-2a)
  • Ribavirin (ribavirin)
  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Ziv Hospital | Conditions: Chronic Hepatitis C | NA | Status: UNKNOWN